Federal Reserve Bank of Atlanta President Raphael Bostic offers his policy outlook, saying he didn’t have any rate cuts projected for the year ahead, and how close he sees the central bank to the neutral rate. He speaks with former Federal Reserve Bank of Atlanta President Dennis Lockhart Monday at an event hosted by the Rotary Club of Atlanta. (Source: Bloomberg)

ablokhin Atlanta Fed President Raphael Bostic said on Monday the U.S. economy remained remarkably strong in 2025, and his outlook for 2026 "is the continuation of a resilient economy." Business leaders in the Atlanta Fed's region generally expect economic growth to continue at the same pace as 2%-2.5%, which suggests that 2026 growth will continue to be strong, he said. Furthermore, the tax bill passed last year, deregulation, and the Fed cutting rates by 175 basis points in the past 18 months will contribute to growth this year. "That's all stuff to help the economy move more robustly, not less," he said. Strong economic performance in the first half of 2026 "will limit the extent to which inflation can fall," Bostic said. Inflation has been “going sideways” for most of the last two years, he noted. "I don't think we're going to see dramatically different things for the first half of 2026. That's going to be a source of concern." In addition, the outlook for the labor market has improved, he said, adding that he doesn't expect any calamity on the labor side of the Fed's mandate. With inflation staying above the central bank's 2% goal, policy decisions will still be challenging, he remarked. Bostic said he penciled in no rate cuts in his Summary of Economic Projections in December. "I think that we have so much momentum in the economy that we need to keep our policy rate in a mildly restrictive stance." Note that Bostic is retiring at the end of his term, which concludes on Feb. 28, 2026. Looking at companies' profits, "I think it's hard to make the case that our policy stance is heavily restrictive or strongly restrictive," he added. More on the US Economy The U.S. Dollar's Slide Has Been A Tailwind For Investing In Foreign Markets ISM Manufacturing PMI expands for the first time in a year in January St. Louis Fed's Musalem says lowering rates now would be 'unadvisable' Why Fed Governor Waller thinks more rate cuts are needed

格隆汇2月3日｜美国天然气期货日内暴跌27.00%，现报3.178美元/百万英热。

March ICE NY cocoa (CCH26) today is up +41 (+0.98%), and March ICE London cocoa #7 (CAH26) is up +76 (+2.61%). Cocoa prices are moving higher today as signs of smaller cocoa deliveries to ports in the Ivory Coast have prompted some short covering in cocoa futures. Today's cumulative data showed that Ivory Coast farmers shipped 1.23 MMT of cocoa to ports in the current marketing year (October 1, 2025, through February 1, 2026), down -4.7% from 1.24 MMT in the same period a year ago. The Ivory Coast is the world's largest cocoa producer. Don’t Miss a Day: Last Friday, NY cocoa dropped to a 2.25-year nearest-futures low, and London cocoa sank to a 2.5-year nearest-futures low as abundant global supplies and slack demand are keeping pressure on cocoa prices. StoneX last Thursday forecasted a global cocoa surplus of 287,000 MT in the 2025/26 season and a 267,000 MT surplus for 2026/27. Also, the International Cocoa Organization (ICCO) reported on January 23 that global cocoa stocks rose 4.2% y/y to 1.1 MMT. Demand concerns have hammered cocoa prices as consumers continue to balk at the high price of chocolate. Last Wednesday, Barry Callebaut AG, the world's largest bulk chocolate maker, reported a -22% decline in sales volume in its cocoa division for the quarter ending November 30, citing "negative market demand and a prioritization of volume toward higher-return segments within cocoa." Grinding reports also showed weak demand. On January 15, the European Cocoa Association reported that Q4 European cocoa grindings fell -8.3% y/y to 304,470 MT, a bigger decline than expectations of -2.9% y/y and the lowest for a Q4 in 12 years. On December 16, the Cocoa Association of Asia reported that Q4 Asian cocoa grindings fell -4.8% y/y to 197,022 MT. Also, the National Confectioners Association reported Q4 North American cocoa grindings rose only +0.3% y/y to 103,117 MT. Since posting a 10.5-month low of 1,626,105 bags on December 26, ICE-monitored cocoa inventories held in US por...

is a senior reporter who’s been covering and reviewing the latest gadgets and tech since 2006, but has loved all things electronic since he was a kid. Posts from this author will be added to your daily email digest and your homepage feed. Following an initial price increase announced two months ago, Raspberry Pi is raising prices again for several of its single-board computers. “The cost of some parts has more than doubled over the last quarter,” Raspberry Pi CEO Eben Upton said in an announcement today. “As a result, we now need to make further increases to our own pricing, affecting all Raspberry Pi 4 and 5, and Compute Module 4 and 5, products that have 2GB or more of memory.” In December, the Raspberry Pi 4 and Raspberry Pi 5 saw price increases from $5 to $25, depending on the amount of RAM included, while the 16GB version of the Compute Module 5 jumped by $20. Starting soon, prices will increase again by $10 for those same devices with 2GB of memory, by $15 for 4GB models, by $30 for 8GB variants, and by $60 for configurations with 16GB of RAM. Today’s price increases don’t affect the price of the 1GB version of the Raspberry Pi 5 that launched two months ago, the 1GB Raspberry Pi 4 variant, or the Raspberry Pi 400 all-in-one PC. It also doesn’t affect the Raspberry Pi 3, Raspberry Pi Zero, or other older products, as Upton says the company holds “several years’ inventory of the LPDDR2 memory that they use.” Looking ahead, Upton says “2026 looks likely to be another challenging year for memory pricing,” but believes “the current situation is ultimately a temporary one, and we look forward to unwinding these price increases once it abates.”

(RTTNews) - Swiss stocks closed on a strong note on Monday, in line with other markets in Europe, thanks to encouraging retail sales and manufacturing activity data. The benchmark SMI closed with an impressive gain of 220.85 points or 1.67% at 13,409.11, the day's high. Nestle climbed about 2.85%, Richemont, Logitech International, Amrize, Novartis, Lindt & Spruengli, Galderma Group, Schindler Ps and UBS Group gained 2%-2.5%. Helvetia Baloise Holding, Holcim, Zurich Insurance, SGS, ABB, Sika, Julius Baer, Swiss Life Holding and Roche Holding moved up 1%-2%. Sonova ended down by about 1.1%. Alcon, VAT Group, Givaudan and Partners Group slipped 0.3%-0.7%. A report from the Federal Statistical Office showed Swiss retail sales increased at the fastest pace in six months in December. The report said retail sales climbed 1% on a monthly basis in December in real terms, reversing a 0.1% fall in November. Sales of food, drinks, and tobacco increased 1.3%, while those of non-food products dropped 0.4%. On a yearly basis, retail sales growth accelerated to 2.9% in December from 1.7% in November. That was above the expected increase of 2.5%. Online sales were 10.8% higher, recovering sharply from a 13.1% plunge in November. Switzerland's procure.ch and UBS manufacturing PMI rose to 48.8 in January 2026 from an upwardly revised 46.4 in December, signalling a modest easing of pressure on the industrial sector. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

baona/iStock via Getty Images The Core Plus Income Fund’s Institutional Class returned +1.26% for the fourth quarter compared to a +1.10% return for the Bloomberg U.S. Aggregate Bond Index (Agg). For the full year, the Core Plus Income Fund’s Institutional Class returned +7.52% compared to a +7.30% return for the index. Longer-term results (3-, 5-, and 10-year) continue to outpace the index. The Core Plus Income Fund has outperformed the Agg six years in a row and eight out of the eleven years since inception. The Fund’s outperformance for the year was driven by sector allocation, led by out-of-benchmark exposures in securitized products, and by security selection, particularly within high yield corporates. Overview The year featured a continuation of the AI-driven rally in equities, Federal Reserve rate cuts to support a softening labor market, and a near "everything rally" that delivered positive returns for both stocks and bonds—the first such broad positive year since the pandemic era. Bonds delivered a strong rebound, benefiting from Fed easing [three 25 basis point ( BPS ) rate cuts in the second half, totaling 75 bps for the year] and attractive starting yields. This provided both income and capital appreciation as the yield curve shifted lower. The yield curve steepened (short rates fell more than long), reflecting Fed cuts amid sticky longer-term inflation/fiscal concerns. Credit spreads tightened overall, supporting outperformance in riskier fixed income segments. Fixed income acted as a ballast, with positive returns across most categories—providing diversification benefits in a year when stocks and bonds moved more in tandem positively. The chart below provides a view of U.S. Treasury interest rates over time (fourth quarter and year- over-year) across the yield curve. A broad gauge of the U.S. Treasury market posted its best return last year since 2020, principally driven by declining interest rates in ten-year and less maturities (see following table)....

Intel was once the leader of America's semiconductor industry but Alphabet's partner Broadcom is looking like the stronger play in the long term. The U.S. government made headlines last year when it invested $8.9 billion into Intel and the announcement caused Intel's shares to grow through the last four months of 2025. But did the government bet on the wrong horse in the artificial intelligence (AI) hardware race? Lots of people piled into Intel when the government announced its investment, but I don't think Intel is the best American semiconductor play, even after an almost $9 billion lifeline from Washington. Intel has been on the decline for years with its annual revenue dropping every year since 2021 and more losses projected for the first quarter of 2026. It's also projecting earnings per share (EPS) of $0 for the first quarter of 2026, which isn't an auspicious start to the year. What's more, the company's big reinvestment in American semiconductor production is struggling. Intel's proposed $28 billion factory in Ohio was originally meant to start production last year. But now Intel isn't projecting it will open until 2030 at the earliest, potentially even 2031. Intel may once have led America's and the world's semiconductor industry, but America's semiconductor renaissance will likely fall to another company. I've written before about Alphabet's (GOOG +1.64%) (GOOGL +1.66%) emergence as a serious contender in the generative AI to the point where it has nearly displaced OpenAI in the enterprise large language model (LLM) market. But what I haven't talked about is the hardware that Alphabet is running its Gemini AI program on. Because, after all, Alphabet is primarily a software company, not a hardware one. And the company Alphabet works with on its Tensor Processing Unit (TPU), which stole headlines late last year, stands to be an even bigger winner of Alphabet's AI investment. Broadcom (AVGO +0.71%) is one of Alphabet's major partners and it has been working ...

Forget Intel: This Smartphone and Auto Chip Giant Is Quietly Building the Better Long‑Term AI Story Yahoo Finance

Key Points Despite a $9 billion investment from Uncle Sam, Intel's decline is continuing unabated. Broadcom is a rising star in the AI hardware industry with 50% of its most recent quarter's revenue coming from AI companies. With an operating margin of 40.8% and 24% revenue growth year over year, Broadcom looks to be the stronger chip play by far. 10 stocks we like better than Broadcom › The U.S. government made headlines last year when it invested $8.9 billion into Intel and the announcement caused Intel's shares to grow through the last four months of 2025. But did the government bet on the wrong horse in the artificial intelligence (AI) hardware race? Lots of people piled into Intel when the government announced its investment, but I don't think Intel is the best American semiconductor play, even after an almost $9 billion lifeline from Washington. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Intel has been on the decline for years with its annual revenue dropping every year since 2021 and more losses projected for the first quarter of 2026. It's also projecting earnings per share (EPS) of $0 for the first quarter of 2026, which isn't an auspicious start to the year. What's more, the company's big reinvestment in American semiconductor production is struggling. Intel's proposed $28 billion factory in Ohio was originally meant to start production last year. But now Intel isn't projecting it will open until 2030 at the earliest, potentially even 2031. Intel may once have led America's and the world's semiconductor industry, but America's semiconductor renaissance will likely fall to another company. I've written before about Alphabet's (NASDAQ: GOOG) (NASDAQ: GOOGL) emergence as a serious contender in the generative AI to the point where it has nearly displaced OpenAI in the enterprise large language model (LLM) market. But what I haven't talked about is the hardware that Alph...

Palantir (PLTR) Anticipates Volatility Ahead of Earnings Release GuruFocus

Apple Proves Naysayers Wrong Yet Again: Maintain Buy Rating (NASDAQ:AAPL) Seeking Alpha

ozgurdonmaz/iStock Unreleased via Getty Images Executive Summary I last covered Apple ( AAPL ) after its stunning 2025 third-quarter earnings, and you can read about it here . The magnitude of their revenue beat convinced me to upgrade my rating from a Hold to a Buy at the time, and I suggested a good price target at $225. It's been a few quarters, and we have blown right through my targets. I felt I needed to observe more than one quarter to write about it to see if that was a one-off earnings surprise. To be honest, I never had doubts about this company. The company reported another stunning 2026 first-quarter earnings, and I must say this was truly one meant for the record books. It posted quarterly revenue of $143.8B, up 16% year over year (YoY). Gross margin for the company came in at an impressive 48.2% due to products this time. The product gross margin came in at a whopping 40.7%, and service gross margin came in at an impressive 76.5%. I must say I was stunned, and I knew I had to write about it and explain the what's and why's to my readers. Investment Thesis: Products Meet Services Products In my previous article, I did something different that not many authors or analysts do. I completely ignored the iPhones to lay out my thesis around service revenues. This segment is often ignored or not appreciated enough. Well, what can I say? The company just proved the naysayers wrong on products and how strong the iPhone numbers were for this quarter. I am sure this is going to change a lot of the analysts' models and theses out there, prompting me to talk about it first. Time and time again, I see analysts questioning Apple's execution strategy and ultimately being proven wrong. Every quarter, there is something or the other that hits the headlines, and analysts are quick to take a stand against this company's performance for the quarter - Tariffs, lack of appeal/innovation, and the recent news on memory prices. Well, at least for the first quarter, soaring memor...

Oracle (NYSE:ORCL) Shares Gap Up - Time to Buy? MarketBeat

格隆汇2月3日｜市场消息：美国将于2月4日主办关键矿产部长级会议。

Rivian and BYD are promising long-term plays on the EV market. The electric vehicle (EV) market's growth has slowed down in recent years, but most analysts still expect EVs to continue replacing gas-powered cars through the end of the decade. According to Grand View Research, the global EV market could still expand at a 32.5% CAGR from 2025 to 2030. To capitalize on that secular trend, investors should consider buying a few shares of Rivian (RIVN 0.51%) and BYD (BYDDY 6.67%). Rivian Rivian produces high-end electric pickups, SUVs, and custom electric delivery vans. When it went public in 2021, it initially claimed it could produce 50,000 vehicles in 2022. However, it produced only 24,337 vehicles that year due to supply chain constraints. Expand NASDAQ : RIVN Rivian Automotive Today's Change ( -0.51 %) $ -0.07 Current Price $ 14.68 Key Data Points Market Cap $18B Day's Range $ 14.43 - $ 14.74 52wk Range $ 10.36 - $ 22.69 Volume 452K Avg Vol 46M Gross Margin -159.38 % Rivian more than doubled its production to 57,232 vehicles in 2023, but it produced only 49,476 vehicles in 2024 amid inflation, higher interest rates, lower EV subsidies, and intense competition. For 2025, it expects to deliver only 40,000 to 46,000 vehicles as it struggles to overcome macro and micro challenges. It also remains unprofitable. However, analysts expect Rivian's revenue to grow at a 31% CAGR from 2024 to 2027 as it narrows its losses. Its biggest near-term catalysts will be the launch of its more affordable R2 SUV, the opening of its Georgia plant, and its partnership with Volkswagen (VWAP.Y 0.49%). That's a bright outlook for a stock that trades at less than three times this year's sales. BYD BYD was originally a battery maker, but over the past two decades, it has evolved into China's largest automaker. In 2022, it stopped producing gasoline-only vehicles to expand its lineup of plug-in hybrid EVs (PHEVs) and battery-powered EVs (BEVs). It differentiated itself from its competitors by d...

Microsoft (MSFT) just landed a massive $750 million cloud deal with AI search startup Perplexity, but investors aren't exactly celebrating, given MSFT stock tanked 10% following the company's latest earnings report. According to a Bloomberg report, the Perplexity deal could be a key win for Microsoft's Azure cloud business. The deal allows the AI search company to deploy models from OpenAI, Anthropic, and xAI through Microsoft's Foundry service. It's a strategic move that diversifies Perplexity's cloud infrastructure beyond its primary partner, Amazon Web Services (AMZN). However, Wall Street's reaction to Microsoft's earnings tells a different story about investor confidence. The Earnings Miss that Spooked Investors Microsoft's fiscal second-quarter results on Jan. 29 weren't terrible by any measure. Revenue hit $81.27 billion, beating the $80.27 billion consensus. Adjusted earnings per share came in at $4.14, topping expectations of $3.97. However, Azure cloud revenue growth of 39% fell short of the 39.4% consensus forecast. More concerning, guidance for the More Personal Computing segment—which includes Windows—came in at roughly $12.6 billion, well below the $13.7 billion analysts expected. The market's response was swift and brutal. Shares plunged 10% the following day, the stock's worst single-day performance since March 2020. The selloff erased $357 billion from Microsoft's market cap, leaving it valued at $3.22 trillion. CFO Amy Hood argued the Azure number could have been higher if Microsoft had allocated more data center capacity to external customers rather than prioritizing internal needs like Microsoft 365 Copilot and GitHub Copilot. "If I had taken the GPUs that just came online in Q1 and Q2 and allocated them all to Azure, the KPI would have been over 40%," Hood explained during the earnings call. Microsoft’s Infrastructure Dilemma Notably, Microsoft spent $37.5 billion on data centers and equipment in the quarter, up 66% from a year ago and above the...

Enigmatic CEO Jensen Huang called the potential investment "huge." At an event in Taipei this weekend, CEO Jensen Huang made a splash when he said Nvidia (NVDA 0.73%) will participate in OpenAI's latest funding round, potentially making "the largest investment we've ever made." "We will invest a great deal of money," Huang told reporters at the event. "I believe in OpenAI. The work that they do is incredible. They're one of the most consequential companies of our time." While Huang didn't specify exactly how much the investment would be, he did say it would be "huge." The start of something big? OpenAI is in talks to raise as much as $100 billion from a number of well-heeled investors, including Nvidia, Microsoft, Amazon, and SoftBank. This funding round could value OpenAI at $750 billion, making it one of the world's most valuable private companies. Last September, Nvidia announced a "landmark strategic partnership," in which OpenAI would deploy at least 10 gigawatts of AI data centers using millions of the chipmakers next-generation Vera Rubin graphics processing units (GPUs). At the time, Nvidia said it intended to invest up to $100 billion in OpenAI as each gigawatt was brought online. Huang's comments come on the heels of a report that suggested the $100 billion deal was on the rocks, according to The Wall Street Journal. The report, which cited "people familiar with the matter," suggested Nvidia was having second thoughts about the size of the investment, noting that the deal was "nonbinding." When asked about the report, Huang replied, "That's nonsense." When asked if the current investment would be $100 billion, he replied, "No, no, nothing like that. Expand NASDAQ : NVDA Nvidia Today's Change ( -0.73 %) $ -1.40 Current Price $ 189.73 Key Data Points Market Cap $4.6T Day's Range $ 186.43 - $ 190.29 52wk Range $ 86.62 - $ 212.19 Volume 3.3M Avg Vol 182M Gross Margin 70.05 % Dividend Yield 0.02 % Investors have been increasingly concerned about the circular na...

Key Points Nvidia plans to participate in OpenAI's latest funding round, which could value the company at $750 billion. The chipmaker already has a partnership with the start-up, supplying next-generation Vera Rubin GPUs for its AI-centric data centers. This is one of many investments Nvidia has made in the AI space, so this isn't anything new. 10 stocks we like better than Nvidia › At an event in Taipei this weekend, CEO Jensen Huang made a splash when he said Nvidia (NASDAQ: NVDA) will participate in OpenAI's latest funding round, potentially making "the largest investment we've ever made." "We will invest a great deal of money," Huang told reporters at the event. "I believe in OpenAI. The work that they do is incredible. They're one of the most consequential companies of our time." While Huang didn't specify exactly how much the investment would be, he did say it would be "huge." Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » The start of something big? OpenAI is in talks to raise as much as $100 billion from a number of well-heeled investors, including Nvidia, Microsoft, Amazon, and SoftBank. This funding round could value OpenAI at $750 billion, making it one of the world's most valuable private companies. Last September, Nvidia announced a "landmark strategic partnership," in which OpenAI would deploy at least 10 gigawatts of AI data centers using millions of the chipmakers next-generation Vera Rubin graphics processing units (GPUs). At the time, Nvidia said it intended to invest up to $100 billion in OpenAI as each gigawatt was brought online. Huang's comments come on the heels of a report that suggested the $100 billion deal was on the rocks, according to The Wall Street Journal. The report, which cited "people familiar with the matter," suggested Nvidia was having second thoughts about the size of the investment, noting that the deal was "nonbinding." When asked about th...

Getty Images Introduction and Thesis The share price of Alaska Air Group ( ALK ) has fallen 37% from its February 2025 peak. Since then, the share price has traded in a wide range between $37 and $66, standing today at $53 per share. This description of events is reflected in the chart below. The drawdown reflects a negative earnings re-rating driven by softer demand since February, higher fuel-related margin pressure, and technology-related operational disruptions that increased costs and weighed on traveler confidence. Seeking Alpha My thesis is that the stock is undervalued at today’s price. I think that what happened last year was a series of incidents or setbacks that in turn created excessive selling pressure on the stock. As we will see later, the company is improving its revenues and its proposed combination with Hawaiian Airlines , which remains subject to regulatory approval and customary closing conditions. It's meeting the milestones set by its management, which, combined with an increase in revenues and a decrease in costs, leads me to consider the thesis as a risky tactical purchase. I do not believe this is a suitable investment for everyone due to its situation, and only readers who are willing to accept high volatility should buy, with a limit of 3-5% of their portfolio. For everyone else, I recommend staying out of the market for the time being. To give readers some context, Alaska Air Group operates Alaska Airlines and Horizon Air and has a proposed combination with Hawaiian Airlines pending regulatory approval, establishing a loyalty business model that seeks to monetize beyond airline tickets themselves. It's one of the largest U.S. air carriers and has a network of ancillary services such as McGee Air Services (airport services). The Business Model and Operating Segments: How Alaska Makes Money Company Website The slide above outlines management’s four profit levers. It does so through four levers, such as Network (400M), Product (100M), Loyalt...

VenHub Global (VHUB) said Monday it appointed Ian Rasmussen as executive vice president of global ex Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles.

格隆汇2月3日｜投票结果显示，法国政府在议会挺过第二次预算的不信任投票。

Silver Place/iStock via Getty Images Investment Thesis I reiterate my buy recommendation on assets that track the main American indices, especially the S&P 500 Index ( SP500 ). This article is part of my weekly series on macroeconomics that started in 2024, and my intention is to analyze the returns for the remainder of the year when the S&P 500 rises in January. I will also analyze a curious rotation that occurred and present the results of my recommended stock portfolio. Context In the last week, we had the appointment of the new FED president and divergent corporate earnings releases, and the S&P 500 touched 7,000 points for the first time. It took 446 days for the index to go from 6,000 points on 11/8/2024 to its current level, and this shows the strong momentum of the market. S&P 500 Index Milestones Level Date Days to Milestone 7,000 1.28.2026 446 6,000 11.8.2024 274 5,000 2.8.2024 1044 4,000 4.1.2021 631 3,000 7.10.2019 1780 2,000 8.25.2014 6048 1,000 2.2.1998 - Click to enlarge I defend my optimistic view for the American stock market every week. However, there are several comments from skeptical investors. It is important to remember that large winning streaks are not uncommon in the American market. Not to mention that there are many more positive years than negative ones in the last 152 years. S&P 500 Returns (Voronoi) But I am not here to talk about such long periods of time. In this sense, we saw an interesting rotation in January 2026, as the Magnificent Seven were surpassed by the other 493 companies. Mag7 vs Other 493 Companies (ZeroHedge) In parallel, there was a large flow of investments into cyclical sectors such as financials, industrials, and materials. Many investors complained that returns were concentrated in a few technology companies; well, this could be the beginning of a contrary movement. Global Sector Flows (EPFR, DB) The Main Insight of the Week Now comes that moment where I share the insight that most caught my attention when creating...

Novo Nordisk just introduced a GLP-1 pill, but the company makes more than just weight-loss drugs. The big story in the pharmaceutical sector has been the emergence of GLP-1 weight-loss drugs. Novo Nordisk (NVO 0.73%) was an early leader in the space. However, Eli Lilly's (LLY +0.66%) GLP-1 version quickly surpassed it, prompting some on Wall Street to dump Novo Nordisk and buy Eli Lilly. But Novo Nordisk could be the better bargain if you think long-term. Wall Street likes a good story Investors can be pretty irrational over short periods, often rushing like lemmings into hot stocks. That's what appears to be happening among investors buying GLP-1 stocks today. When Novo Nordisk introduced Ozempic to the world, investors jumped on board, recognizing the significant impact this diabetes drug could have on patients seeking help with weight-loss. It began marketing a drug, Wegovy, specifically to help with weight loss. When Eli Lilly's GLP-1 variation, Mounjaro (for diabetes) and Zepbound (for weight loss), proved more attractive to patients, Novo Nordisk's stock tanked, while Eli Lilly's rose. There's really nothing shocking in any of this. Wall Street operates like this all the time. Yet there are implications to consider when stocks move up and down in dramatic fashion. One of the biggest considerations is valuation, which is more art than science. But the effect of the different price moves here has been pretty clear. Eli Lilly's price-to-earnings ratio (P/E) is a lofty 50, while Novo Nordisk's is around 18. Lilly's P/E is currently below its five-year average of 55, but Novo Nordisk's five-year average P/E is 30. All in, the latter is cheaper on both an absolute basis and relative to its own history. Novo Nordisk is offering a generous 2.8% dividend yield versus a miserly 0.6% yield for Eli Lilly. Novo Nordisk isn't just a GLP-1 maker To be fair, you could argue that Novo Nordisk isn't the leader in the GLP-1 space. That's true, but it is still an innovative phar...

CR/iStock via Getty Images Novo Nordisk's ( NVO ) next-generation weight loss medicine CagriSema led to greater weight loss compared to those taking the pharma's other obesity drug, Wegovy (semaglutide). At 68 weeks, those on CagriSema, a combination of cagrilintide and semaglutide, achieved 14.2% weight loss, compared to 10.2% for those on Wegovy. Cagrilintide is an amylin receptor agonist, while semaglutide is a GLP-1 receptor agonist. Topline results from the phase 3 REIMAGINE 2 trial also showed that those on CagriSema had an HbA1C reduction of -1.91 points compared to -1.76 points with Wegovy. CagriSema was given once weekly via subcutaneous injection. Novo Nordisk submitted an application for CagriSema with the US FDA in December. More on Novo Nordisk Novo Nordisk: Momentum Meets Headwinds Before Earnings (Upgrade) Novo Nordisk: Investors May Be In For An Earnings Surprise Novo Nordisk: The Q4 Setup Favors Another Beat (Earnings Preview) Trump admin negotiates 71% discount on Ozempic, Wegovy for Medicare patients Seeking Alpha’s Quant Rating on Novo Nordisk A/S

Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." A meltdown in metals rattles markets, setting off a domino effect in stocks as investors brace for a possible Warsh-led Fed. In AI, Oracle eyes a massive $50-billion funding push while Nvidia’s CEO cools expectations around OpenAI. And on earnings—Disney’s outlook disappoints as a new CEO contender emerges, while Porsche weighs cutting electric sports cars to rein in costs. (Source: Bloomberg)

The materials sector is showing signs of life with an impressive 8.64% gain for the S & P 500 Materials Index in January. This strength reflects improved long-term momentum for the sector, both on an absolute basis and relative to the S & P 500 Index (SPX) . This prompted us to review the sector from a bottom-up perspective, and we discovered Dow Inc. (DOW) as a chemical stock undergoing a potential turnaround. In the second half of 2025, DOW found a footing near long-term support from the 2020 low, near $22. After a strong showing in January, the stock flashed a new long-term oversold upturn, indicating a major low has likely been established on the chart. Long-term momentum has also improved, as reflected by the monthly MACD. In mid-January, DOW broke out above its 200-day (40-week) moving average (MA) and has pushed into the weekly cloud (above $28.00) after digesting its earnings report. The weekly MACD is turning positive in a bullish intermediate-term development, suggesting DOW will see upside follow-through over the next 2-3 months. The top of the cloud is the next major resistance level on the chart, which meets with a Fibonacci retracement level near $35.80 in mid-April. On the daily chart, initial support is well-defined by former highs from last September and October, which roughly align with the 200-day moving average near $25.50. Because turnaround opportunities are higher risk in nature, we recommend using a stop-loss to manage risk. Consecutive daily closes below $25.50 would be a reason to reduce exposure. Finding opportunities in former laggards that have new catalysts can be additive to performance at the portfolio level. DOW appears to be emerging from a long-term base with improving momentum, suggesting it can rebound in 2026 alongside the broader materials sector. —Katie Stockton with Will Tamplin Access research from Fairlead Strategies for free here . DISCLOSURES: None. All opinions expressed by the CNBC Pro contributors are solely their opin...

格隆汇2月3日｜市场消息：在两项不信任动议均告失败后，法国已通过2026年预算案。